Leidos Biomedical Research, Inc.
US H-1B Labor Condition Application activity for Leidos Biomedical Research, Inc.. Filed 229 disclosures between FY2014 and FY2026 from worksites with a MD headquarters indicator.
H-1B outcome breakdown
Share of Leidos Biomedical Research, Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 90.4% |
| Cert-withdrawn | 0.9% |
| Withdrawn | 7.9% |
| Denied | 0.9% |
Top occupations sponsored
SOC codes filed most by Leidos Biomedical Research, Inc. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-1042 | Medical Scientists, Except Epidemiologists | 66 |
| 2 | 19-1029 | Biological Scientists, All Other | 52 |
| 3 | 19-2021 | Atmospheric and Space Scientists | 23 |
| 4 | 15-1252 | Software Developers | 20 |
| 5 | 19-4021 | Biological Technicians | 11 |
| 6 | 15-2051 | Data Scientists | 8 |
| 7 | 19-2031 | Chemists | 7 |
| 8 | 15-1221 | Computer and Information Research Scientists | 7 |
| 9 | 17-2112 | Industrial Engineers | 6 |
| 10 | 15-1251 | Computer Programmers | 5 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2014 | 25 |
| FY2015 | 25 |
| FY2016 | 32 |
| FY2017 | 24 |
| FY2018 | 29 |
| FY2019 | 37 |
| FY2022 | 1 |
| FY2023 | 4 |
| FY2024 | 17 |
| FY2025 | 13 |
| FY2026 | 22 |
| Period | Value |
|---|---|
| FY2014 | 25 |
| FY2015 | 25 |
| FY2016 | 32 |
| FY2017 | 24 |
| FY2018 | 29 |
| FY2019 | 37 |
| FY2022 | 1 |
| FY2023 | 4 |
| FY2024 | 17 |
| FY2025 | 13 |
| FY2026 | 22 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.